Subtype
Female Reproductive System Neoplasm
CI-CAN-00000885Explore in graph →
Non-malignant1,629 active trials11 approved drugs139 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000885Explore in graph →
Clinical trials
7,170 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01982487 | Vaccine Therapy and IDO1 Inhibitor INCB024360 in Treating Patients With Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Are in Remission | withdrawn | Phase 1 / Phase 2 | 0 | Roswell Park Cancer InstituteOTHER | 0 | Dec 18, 2013 | clinicaltrials |
| NCT00768742 | Safety and Effectiveness Study of RF Ablation of Uterine Fibroids to Reduce Menstrual Bleeding: the Fibroid Ablation Study(FAST) | withdrawn | N/A | 0 | GynesonicsINDUSTRY | 1 | Nov 25, 2013 |
| clinicaltrials |
| NCT00072540 | S0212 Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix | withdrawn | Phase 2 | 0 | SWOG Cancer Research NetworkNETWORK | 0 | Nov 8, 2013 | clinicaltrials |
| NCT00382330 | Chemoprevention of Cancer in the Lower Female Genital Tract: The Antineoplastic Activity of the Fungicide Ciclopirox. | withdrawn | N/A | 0 | University of Medicine and Dentistry of New JerseyOTHER | 1 | Sep 6, 2013 | clinicaltrials |
| NCT00085527 | FR901228 in Treating Patients With Relapsed or Refractory Advanced Ovarian Epithelial Cancer | withdrawn | Phase 2 | 0 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00084370 | Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy | withdrawn | N/A | 0 | University of Alabama at BirminghamOTHER | 1 | Aug 22, 2013 | clinicaltrials |
| NCT00017537 | Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer | withdrawn | Phase 1 | 0 | University of Alabama at BirminghamOTHER | 0 | Aug 5, 2013 | clinicaltrials |
| NCT00080639 | CA-125 in Screening Patients at High Risk for Ovarian Cancer | withdrawn | — | 0 | University of Alabama at BirminghamOTHER | 1 | Aug 5, 2013 | clinicaltrials |
| NCT00942838 | Whole Abdomen Radiation in Conjunction With Intraperitoneal Chemotherapy for the Treatment of Small Volume Recurrent Ovarian Carcinoma Limited to the Peritoneal Cavity(WAR) | withdrawn | Phase 1 | 0 | University of UtahOTHER | 1 | Jul 24, 2013 | clinicaltrials |
| NCT01498237 | Photoacoustic Endoscopy in Endometrial Cancer | withdrawn | Early Phase 1 | 0 | Washington University School of MedicineOTHER | 0 | Jul 11, 2013 | clinicaltrials |
| NCT00006267 | Nitrocamptothecin in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer | withdrawn | Phase 2 | 0 | Gynecologic Oncology GroupNETWORK | 0 | Jul 9, 2013 | clinicaltrials |
| NCT00369954 | Gemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Responded to Previous Cisplatin or Carboplatin | withdrawn | Phase 2 | 0 | Gynecologic Oncology GroupNETWORK | 0 | Jun 10, 2013 | clinicaltrials |
| NCT00477867 | Economic Outcomes in Patients With Stage III Ovarian Cancer Receiving Paclitaxel and Cisplatin on Clinical Trial GOG-172 | withdrawn | N/A | 0 | Gynecologic Oncology GroupNETWORK | 0 | Jun 10, 2013 | clinicaltrials |
| NCT00137358 | Radiation With Chemotherapy and a Study Drug to the Para-Aortic Nodes in Cervical Cancer | withdrawn | Phase 1 | 0 | University of Alabama at BirminghamOTHER | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00173407 | PTEN and IGFBP-3 Correlation in Ovarian Carcinoma Invasion | withdrawn | N/A | 0 | National Taiwan University HospitalOTHER | 1 | Dec 27, 2012 | clinicaltrials |
| NCT00460200 | Depression and Interleukin-6 Production in Patients With Ovarian Epithelial Cancer | withdrawn | — | 0 | Jonsson Comprehensive Cancer CenterOTHER | 0 | Oct 4, 2012 | clinicaltrials |
| NCT01661868 | Olaparib for Patients With Recurrent BRCA Deficient Ovarian Cancer | withdrawn | Phase 2 | 0 | Dana-Farber Cancer InstituteOTHER | 1 | Aug 21, 2012 | clinicaltrials |
| NCT01558778 | Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant | withdrawn | N/A | 0 | Roswell Park Cancer InstituteOTHER | 0 | Jul 9, 2012 | clinicaltrials |
| NCT01290406 | BEZ235 Trial in Patients With Advanced Endometrial Carcinoma | withdrawn | Phase 2 | 0 | Novartis PharmaceuticalsINDUSTRY | 12 | Jun 21, 2012 | clinicaltrials |
| NCT00057928 | S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer | withdrawn | Phase 3 | 0 | SWOG Cancer Research NetworkNETWORK | 2 | Jun 13, 2012 | clinicaltrials |
| NCT01313104 | Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or Cancer | withdrawn | N/A | 0 | Northwestern UniversityOTHER | 0 | Jun 11, 2012 | clinicaltrials |
| NCT01031056 | Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers | withdrawn | — | 0 | Stanford UniversityOTHER | 1 | May 28, 2012 | clinicaltrials |
| NCT00813254 | Cost Utility Analysis in Recurrent Ovarian Cancer | withdrawn | — | 0 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 19, 2012 | clinicaltrials |
| NCT00118300 | Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer | withdrawn | Phase 1 | 0 | Case Comprehensive Cancer CenterOTHER | 1 | Jul 8, 2011 | clinicaltrials |
| NCT00328757 | Safety of Regular Diet as the First Meal in Patients Who Underwent Surgical Treatment for Gynecologic Cancer | withdrawn | Phase 3 | 240 | Chiang Mai UniversityOTHER | 1 | Jun 28, 2011 | clinicaltrials |
| NCT01000896 | Study to Assess Safety and Tolerability of AZD0530 in Combination With Carboplatin and Paclitaxel | withdrawn | Phase 1 | 27 | AstraZenecaINDUSTRY | 1 | Feb 4, 2010 | clinicaltrials |
| NCT00610792 | Phase 2 Study of Twice Weekly VELCADE and CAELYX in Patients With Ovarian Cancer Failing Platinum Containing Regimens | withdrawn | Phase 2 | 91 | Millennium Pharmaceuticals, Inc.INDUSTRY | 2 | Jul 14, 2009 | clinicaltrials |
| NCT00451945 | New Indications for Ultrasound in the Staging of Cervical Cancer | withdrawn | N/A | — | Rigshospitalet, DenmarkOTHER | 1 | Jun 18, 2008 | clinicaltrials |
Data updated 22 days agoSource updated Dec 18, 2013source: clinicaltrials